Skip to main content
. 2015 Jan-Mar;6(1):13–23. doi: 10.4103/0976-500X.149138

Supplemental Figure 2.

Supplemental Figure 2

HO-1 block with CrMP was not able to attenuate PD-4-I viability improvement of HepG2 cells. (*P<0.05 vs control, #P<0.05 vs. TNF-α + 50μM CrMP)